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Control of Meiotic and Mitotic Progression
by the F Box Protein -Trcp1 In Vivo
protein, also called Fbw1a) has been reported to be
involved in the degradation of IB family members in
response to NFB activating stimuli (Yaron et al., 1998;
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1999; Spencer et al., 1999; Shirane et al., 1999; WinstonLili Yamasaki,2 and Michele Pagano1,*
et al., 1999; Wu and Ghosh, 1999). In addition, mamma-1Department of Pathology and
lian-Trcp1 controls-catenin stability (Hart et al., 1999;New York University Cancer Institute
Hatakeyama et al., 1999; Kitagawa et al., 1999; LatresNew York University School of Medicine
et al., 1999). All well-characterized substrates of -Trcp1New York, New York 10016
have a conserved destruction motif, DSGxxS, and are2 Biological Sciences
recognized by this Fbp only upon phosphorylation ofColumbia University
the two serine residues present in this motif. A furtherNew York, New York 10027
level of complexity is added by the presence of a3 European Institute of Oncology
-Trcp1 paralogous gene product, called -Trcp2.20141 Milan
-Trcp1 and -Trcp2 are ubiquitously expressed in bothItaly
human and mouse tissues (Cenciarelli et al., 1999; Koike4 Department of Pathology
et al., 2000; Maruyama et al., 2001). In addition, -Trcp2Stanford University School of Medicine
has biochemical properties similar to -Trcp1 in its abil-Stanford, California 94305
ity to sustain the ubiquitinylation of both -catenin and
IB family members in vitro and to control their degrada-
tion in overexpression experiments performed in mam-Summary
malian cultured cells (Fuchs et al., 1999; Tan et al., 1999;
Suzuki et al., 1999). Thus, it is not clear whether theseSCF ubiquitin ligases, composed of three major sub-
two Fbps have overlapping functions in vivo or whetherunits, Skp1, Cul1, and one of many F box proteins (Fbps),
each of them recognizes specific substrates. To investi-control the proteolysis of important cellular regulators.
gate the role of -Trcp1 in normal growth and develop-We have inactivated the gene encoding the Fbp
ment and to determine the substrate selectivity of-Trcp1 in mice. -Trcp1/ males show reduced fer-
-Trcp1 in vivo, we have inactivated the gene encodingtility correlating with an accumulation of methaphase I
this protein in mice by homologous recombination. Thespermatocytes.-Trcp1/ MEFs display a lengthened
results of these studies are herein presented.mitosis, centrosome overduplication, multipolar meta-
phase spindles, and misaligned chromosomes. Fur-
Resultsthermore, cyclin A, cyclin B, and Emi1, an inhibitor of
the anaphase promoting complex, are stabilized in
Generation of -Trcp1/ Micemitotic-Trcp1/MEFs. Indeed, we demonstrate that
A targeting construct was designed to delete codonsEmi1 is a bona fide substrate of -Trcp1. In contrast,
154–212 of the gene encoding mouse -Trcp1, thus re-stabilization of -catenin and IB, two previously re-
moving all but four amino acids of the F box plus anported -Trcp1 substrates, does not occur in the ab-
additional 22 amino acid region downstream of the Fsence of -Trcp1 and instead requires the additional
box (Figure 1A). Chimeric mice were generated that gavesilencing of-Trcp2 by siRNA. Thus,-Trcp1 regulates
germline transmission of the mutant allele. Intercrossingthe timely order of meiotic and mitotic events.
of heterozygous mice yielded -Trcp1/ animals, as
determined by Southern blot analysis (Figure 1B) and
Introduction genomic PCR (Figure 1C). Northern blot (Figure 1D) and
Western blot (Figure 1E) analyses revealed that insertion
F box proteins (Fbps) are characterized by an approxi- of the neoR gene in the opposite transcriptional orienta-
mately 40 amino acid motif called the F box as it was tion prevented expression of -Trcp1 in mouse embry-
first identified in cyclin F (Bai et al., 1996). Fbps play onic fibroblasts (MEFs) and all tissues analyzed (not
a crucial role in the ubiquitin-mediated degradation of shown). -Trcp1 deficiency did not affect the viability
cellular regulatory proteins, being subunits of ubiquitin of -Trcp1/ animals, as shown by the fact that in-
ligases named SCFs because they are formed by the termating of -Trcp1/– mice yielded viable -Trcp1/,
basic components Skp1, Cul1, Roc1/Rbx1, and one of -Trcp1/–, and -Trcp1–/– mice at approximately the ex-
many Fbps (reviewed by Kipreos and Pagano, 2000). pected Mendelian ratio (27.12%, 49.62%, and 23.25%,
Because the substrate specificity of SCF ligases is dic- respectively; n  800).
tated by different Fbps that act as substrate-targeting No obvious difference between the overall health sta-
subunits, large families of Fbps are present in all eukary- tus of -Trcp1-deficient mice and wild-type mice was
otes to ensure high specificity. evident during more than 2 years of observation. Simi-
Mammalian -Trcp1 (-transducin repeat containing larly, autopsy did not show gross tissue abnormalities in
-Trcp1/ mice. The only exceptions that we observed
were one invasive adenocarcinoma of the intestine ob-*Correspondence: michele.pagano@med.nyu.edu
5This author is on sabbatical leave from Hiroshima University. served in a 10-month-old -Trcp1/ mouse and the
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Figure 1. Generation of -Trcp1/ Mice
(A) Genomic organization of the wild-type gene encoding mouse -Trcp1 is shown (top) with the position of coding exons 4–9 indicated. To
generate the targeting vector (middle), the neoR gene was inserted in an antisense orientation to replace codons 154–212 corresponding to
all but four amino acids of the F box of -Trcp1 plus an additional 22 amino acid region downstream of the F box. Homologous recombination
between the wild-type allele and the targeting vector produced the mutant allele (bottom).
(B) Southern blot analysis of wild-type, heterozygous, and homozygous mutant mice. After HindIII digestion, hybridization with a 3 external
probe detects an 8.2 Kbp wild-type allele and a 6.0 Kbp mutant allele.
(C) A genomic PCR analysis was performed to genotype all progeny. Separate PCR reactions with either the unique exon primer (D1) or the
unique neo primer (L90) and a common intron primer (D3) (see PCR primer positions in [A]) were used to detect the wild-type or the mutant
allele, respectively.
(D) Expression of -Trcp1 and -Trcp2 transcripts. Total RNAs were prepared from different batches of MEFs from -Trcp1/ (lanes 1 and
2) and -Trcp1/ (lane 3 and 4) mice and processed for Northern blotting using full-length mouse -Trcp1 (upper panel), -Trcp2 (middle
panel), or -actin cDNA (lower panel).
(E) Expression of -Trcp1 protein. Lane 1: recombinant Flag-tagged -Trcp1 used as a marker. Extracts from -Trcp1/ (lane 2) and -Trcp1/
MEFs (lane 3) were subjected to immunoprecipitation (IP) with an antibody to -Trcp1 followed by immunoblotting analysis (IB) with the same
antibody.
premature death of two -Trcp1/ mice from thymic showed a strong reduction of mature spermatozoa and
the presence of abnormal cells and cellular debris notlymphomas at 6.5 and 19 months of age.
found in wild-type mice (Figures 2A and 2C; n  11,
-Trcp1/ males and n  9, wild-type males). FiguresReduced Fertility and Accumulation of Metaphase I
Spermatocytes in -Trcp1-Deficient Males 2E–2I show histological sections of testes from control
and knockout adult mice. Seminiferous tubules at stageAlthough copulatory behavior was normal and vaginal
plugs were produced, -Trcp1/ males have a fertility VII showed a number of irregularities, including the for-
mation of vacuoles and a smaller number of round sper-defect. In breeding experiments, 50% of the tested
-Trcp1/ males never produced progeny with young matids arranged in irregular patterns (Figure 2F). In addi-
tion, multinucleated cells (arrows in Figure 2F), whichfertile wild-type females (Table 1). In addition, the re-
maining 50% showed reduced fertility, as judged by appear to be abnormal round spermatids, were present.
Frequently, these multinucleated cells were very largethe number of litters generated and the mean litter size
(Table 1). Histological evaluation of the lumen of epidi- in size and contained nuclei of different sizes within
the same single cell (Figure 2I). -Trcp1/ seminiferousdymes from adult -Trcp1/ males (Figures 2B and 2D)
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Table 1. -Trcp1/ Male Mice Have Reduced Fertility
Fraction Fertile
Genotype (Fertile/Total) Litters/Fertile Pair (n) Mean Litter Size (n)
-Trcp1/ 4/4 6.5 7.8
-Trcp1/ 10/10 6.4 7.5
-Trcp1/ 5/10 3.2 2.1
Males (8–12 weeks of age) of the three different genotypes were tested for fertility for a period of approximately 4 months with both virgin
and experienced young wild-type females. Copulatory behavior was judged to be normal and vaginal plugs were regularly found. Fifty percent
of -Trcp1/ mice were sterile and the remaining 50% had reduced fertility as judged by the number of litters generated (p  0.009) and the
mean litter size (p  0.001).
tubules at stage XII showed unusual chromatin figures of the -Trcp1/ cells were unable to do so and re-
mained in mitosis.and the absence of elongated spermatids facing the
lumen (compare Figures 2G and 2H). We also noticed We also analyzed centrosomes and mitotic spindles
in asynchronous populations of early-passage MEFs.that compared to wild-type littermate controls, a larger
number of metaphase I spermatocytes (characterized Most cells from -Trcp1/ and -Trcp1/– mice con-
tained one or two centrosomes juxtaposed to the nu-by the dark metaphase plate) per tubule at stages XII
is present in -Trcp1/ mice (13.6  1.7 in -Trcp1/ cleus. In contrast, a significant fraction of -Trcp1–/–
MEFs contained more than two centrosomes (3–12 perand 8.0  0.3 in -Trcp1/; n  4 for each group; p 
0.005; Figure 2H). Moreover, a fraction of spermatocytes cell; Figure 4A). Quantitative analysis revealed that ab-
normal amplification of the centrosomes was present indisplayed spindle abnormalities and misaligned chro-
mosomes (not shown). The histopathologic defects in 21.5  1.9% of -Trcp1/ MEFs compared with a value
of 3.2 2.8% for-Trcp1/ MEFs (Figure 4B). As showndifferent -Trcp1/ mice paralleled their fertility impair-
ment, as sterile animals showed more severe abnormali- in Figure 4A, centrosome splitting occurs regularly in
-Trcp1/ MEFs, as the supernumerary centrosomesties than those observed in mice with reduced fertility.
Altogether, our data indicate that a prolonged and appeared well separated from each other. In addition,
11.6% of the mitotic -Trcp1/ MEFs showed multipo-abnormal meiosis in spermatocytes may be responsible
for the reduction of postmeiotic spermatids in testes and lar spindles (Figure 4C), indicating that at least a fraction
of the supernumerary centrosomes is mature as spin-mature spermatozoa in epididymes with the consequent
reduced fertility in -Trcp1-deficient males. Thus, these dles organizers. In turn, the abnormalities in spindle
structures are likely to be the cause of the misalignmentresults reveal a role for -Trcp1 in the control of meiosis.
of chromosomes from the metaphase equator observed
by staining condensed chromosomes with an anti-phos-Mitotic Defects and Centrosomal Overduplication
pho-specific antibody to Histone H3 (Figure 4C).in -Trcp1/ MEFs
A prolonged S phase or mitosis can result in centro-To determine whether the meiotic defects observed in
some overduplication. -Trcp1/ MEFs show a delaygerm cells corresponds to a mitotic defect in somatic
in progressing through mitosis but not through the G1-Scells, we used MEFs, where cell cycle alterations can
transition. Thus, the centrosomal overduplication of mu-be studied in greater detail than in vivo. We prepared
tant cells could be attributable to the mitotic defect.MEFs from -Trcp1/ and -Trcp1/ embryos and
Significantly, the mitotic defects of -Trcp1/ MEFs areexamined their cell cycle properties in culture. The
consistent with the meiotic phenotype observed in germcell cycle profiles of asynchronous early-passage
cells.-Trcp1/ and -Trcp1/ MEF cultures were very simi-
lar, as revealed by flow cytometry analysis (Figure 3A).
We then investigated the progression from G1 into S Stabilization of Mitotic Regulators in -Trcp1/
MEFs and Testesphase. -Trcp1/ and -Trcp1/ MEFs were arrested
in G0/G1 by serum deprivation and then reactivated with Because -Trcp1-deficient MEFs displayed delayed mi-
totic progression, we analyzed the expression of cellserum. Following reentry into the cell cycle, the kinetics
of S phase entry were similar in the two genotypes (Fig- cycle regulatory proteins. In agreement with the data
concerning DNA replication (Figures 3A and 3B), follow-ures 3A and 3B). In contrast, when we analyzed the pro-
gression through mitosis, we observed significant differ- ing reentry into the cell cycle, levels of cyclin A and
cyclin B gradually increased with similar kinetics in wild-ences. Cells were arrested in prometaphase using
nocodazole treatment followed by mitotic shake-off. At type and mutant cells (Figure 5A). We then analyzed the
levels of these cell cycle regulators during the M-to-G1various times after replating in fresh medium, cells were
collected and specific mitotic forms were analyzed by transition. Prometaphase cells were allowed to synchro-
nously progress through mitosis and enter into the nextimmunofluorescence (Figures 3C and 3D). Forty-five
minutes after replating, 51.1 5.3% of -Trcp1/ MEFs G1 phase. Significant differences between the two geno-
types were consistently observed in multiple experimentswere either in prometaphase, metaphase, or anaphase,
while only 20.1  6.2% of wild-type cells were still at using different batches of early-passage MEFs obtained
from -Trcp1/ and littermate control mice (a represen-these mitotic stages. By 75 minutes, the differences
were less dramatic, with 85.1% of wild-type cells having tative example is shown in Figure 5B). As expected (Gi-
rard et al., 1995), cyclin A and cyclin B were present inexited mitosis and entered the next G1, whereas 26.0%
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Figure 2. Defective Spermatogenesis and Accumulation of Metaphase I Spermatocytes in -Trcp1/ Mice
(A–D) Histology of epididymis. The histological sections were stained with H&E (A and B) and DAPI (C and D). The panels to the left (A and
C) show the epididymis histology of wild-type mice; the panels to the right (B and D), that of –Trcp1/ animals.
(E–I) Testicular histology. The panels to the left (E and G) show the testicular histology of wild-type mice; the panels to the right (F, H, and I),
that of -Trcp1-deficient animals. Top panels show seminiferous tubules at stage VII (E and F); bottom panels show seminiferous tubules at
stage XII (G and H). Arrows in (F) point to multinucleated cells (some of which are magnified in [I]).
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Figure 3. Mitotic Phenotype in -Trcp1/ MEFs
(A) Flow cytometry profiles of -Trcp1/ (top) and -Trcp1/ MEFs (bottom). Asynchronous populations (AS) were serum starved for 72 hr
(SS), trypsinized, and then reactivated to reenter the cell cycle with 20% serum for 24 hr.
(B) Time course of DNA synthesis after reactivation with serum. DNA synthesis was monitored by adding BrdU in the last 2 hr of culture
followed by immunostaining at the time points indicated in the figure.
(C and D) -Trcp1/ MEFs show a prolonged mitosis.
(C) MEFs were stained 45 min after release from prometaphase with DAPI (to visualize DNA), an anti--tubulin antibody (to visualize microtubules
and identify mitotic forms), and an anti-phospho-specific antibody to Histone H3 (to visualize condensed chromosomes characteristic of
mitotic cells).
(D) Specific mitotic forms were quantified at different times after release from prometaphase. The results shown on the left are the mean
percentage obtained from four independent experiments using different batches of early-passage MEFs obtained from -Trcp1/ and
littermate control mice.
both wild-type and -Trcp1/ prometaphase cells, but -Trcp1/ cells (Figure 5B, compare lanes 1 and 5).
When prometaphase -Trcp1/ MEFs progresseddisappeared with significantly different kinetics. By 45
min, most cyclin A was degraded in -Trcp1/ MEFs through mitosis, Emi1 levels slowly decreased (Figure
5B, lanes 6–8). At later time points, when most cells hadbut approximately 50% was still present in -Trcp1-
deficient cells. Likewise, cyclin B degradation was de- entered G1, Emi1 was almost totally degraded (Figure
5B, lane 10). We also looked at the progression throughlayed in -Trcp1/ MEFs.
Because -Trcp1-deficient cells progress slowly mitosis using a different synchronization method. Cells
were arrested in early S phase by first culturing in me-through mitosis and degrade both cyclin A and cyclin
B with delayed kinetics, we reasoned that the APC/C dium containing low serum and then releasing them into
complete medium containing aphidicolin. MEFs were(anaphase promoting complex/cyclosome) might be in-
hibited in these cells. A well-established negative regu- harvested at different times after release from the S
phase block and analyzed by immunoblotting for thelator of APC/C is Emi1 (early mitotic inhibitor 1), which
is upregulated during S and G2 and degraded early in levels of mitotic regulatory proteins (Figure 5C). Entry
into mitosis was examined with an anti-phospho-spe-mitosis to allow for the activation of APC/C (Hsu et al.,
2002). We therefore analyzed the levels of Emi1 during cific antibody to Histone H3 used in immunoblotting
(Figure 5C) and immunofluorescence (not shown). Al-cell cycle progression. Whereas Emi1 expression during
the G1-to-S transition was similar in wild-type and mu- though the majority of MEFs from both genotypes
reached mitosis by 9 hr after aphidicolin release, atant MEFs (Figure 5A), Emi1 was present in prometa-
phase -Trcp1-deficient MEFs but not in prometaphase lengthened progression through mitosis and a delayed
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Figure 4. -Trcp1/ MEFs Display Centrosome Overduplication, Multipolar Spindles, and Misaligned Chromosomes
(A and B) Overduplication of centrosomes in -Trcp1–/– MEFs.
(A) MEFs from -Trcp1/ (two panels on the left) and -Trcp1/ (two panels on the right) mice were stained with anti-	-tubulin antibody
(red) to stain the centrosomes and with DAPI (blue) to stain DNA.
(B) Quantitative analysis of centrosome number. Data are expressed as the percentage of cells that contained the indicated number of
centrosomes.
(C) Multipolar spindles and misaligned chromosomes in -Trcp1–/– cells. MEFs were stained with DAPI (to visualize DNA), an anti--tubulin
antibody (to visualize mitotic spindles), and an anti-phospho-specific antibody to Histone H3 (to visualize condensed chromosomes).
kinetics of degradation for Emi1 and cyclin A were ob- in 45 min but then the remaining fraction is stable for
up to 75 min. In contrast, Emi1 is completely stable inserved in -Trcp1/ MEFs. Thus, in wild-type MEFs,
Emi1 has the expected timing of expression and degra- -Trcp1/ MEFs.
Finally, we analyzed levels of Emi1, cyclin A, and twodation (Hsu et al., 2002), whereas in -Trcp1-deficient
MEFs it behaves aberrantly, accumulating in prometa- previously reported -Trcp1 substrates (IB and
-catenin) in 16 different mouse organs from wild-typephase. Importantly, this accumulation correlated with a
stabilization of the protein as shown by measuring its and -Trcp1-deficient mice (representative examples
are shown in Figure 5E). We observed an accumulationhalf-life by two different methods. First, prometaphase
cells were incubated with cycloheximide to inhibit pro- of Emi1 and cyclin A in testes of -Trcp1/ mice but
not in other organs. The extent of this accumulation istein synthesis, and then the rate of Emi1 degradation
was followed by immunoblotting (Figure 5D, second panel likely to be underestimated, as the extract from testes
also included a majority of nonmetaphase cells in which,from the top). We also estimated Emi1 degradation by a
pulse-chase procedure, but due to the limited size of early- based on the results in MEFs, -Trcp1 deficiency is not
predicted to affect Emi1 levels.passage MEF cultures, we could not use a pure population
of cells in prometaphase. We therefore enriched the
G2-M population by incubating the MEF culture with Emi1 Is a Bona Fide Substrate of -Trcp1
After observing a stabilization of Emi1 in -Trcp1/nocodazole prior to the pulse-chase with 35S-labeled
amino acids (Figure 5D, bottom panel). The half-life of MEFs, we noticed that this protein contains a DSGxxS
-Trcp1 binding domain that is conserved among spe-Emi1 measured in wild-type cells is consistent with a
mixed population consisting of mitotic cells, in which cies (Figure 6A), suggesting that Emi1 might be a direct
substrate of -Trcp1. To test this possibility, we trans-Emi1 has a short half-life, and G2 cells, in which Emi1
is stable. In fact, approximately 50% of Emi1 is degraded fected MEFs with Myc-tagged wild-type Emi1 or an Emi1
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mutant in which both serine residues of the DSGxxS induction of IB degradation and resynthesis in
motif have been mutated to alanine [Emi1(S145A/S149A) -Trcp1/ cells with any stimulus and in all cell types
mutant]. We then synchronized cells in prometaphase, tested. NFB DNA binding activity was either identical
measured Emi1 half-life by the addition of cyclohexi- in the two genotypes or occasionally reduced in
mide, and found that wild-type Emi1 was stabilized in -Trcp1/ cells (compare lanes 3 and 4 to lanes 7 and
-Trcp1/ cells (Figure 6B, second panel from the top). 8 in Figures 7D and 7E).
In contrast, Emi1(S145A/S149A) mutant was stable in Basal levels of -catenin are identical in -Trcp1/
MEFs from both genotypes (Figure 6B, bottom panel). and -Trcp1/ MEFs (Figure 7F, lanes 1 and 2), as well
To test whether a difference in Emi1 degradation corre- as in a number of tissues examined (Figure 5E). We
sponds to a difference in its ubiquitinylation, we devel- tested whether -catenin degradation was impaired
oped a cell-free assay for Emi1 ubiquitinylation using after release from a Wnt3a-mediated -catenin accumu-
extracts from prometaphase MEFs. Using this assay, lation. After treatment with Wnt-3a for 2 hr, -catenin
we found that Emi1-ubiquitin ligation activity is higher increased substantially in both -Trcp1/ and
in an extract from wild-type prometaphase MEFs than -Trcp1/ cells (Figure 7F, lanes 3 and 7), and after
from -Trcp1-deficient prometaphase MEFs (Figure 6C, Wnt3a withdrawal, levels of -catenin were consistently
lanes 1–8). Emi1(S145A/S149A) mutant was not ubiquiti- and timely restored in MEFs from both genotypes (Fig-
nylated by either extract (not shown). Importantly, the ure 7F). Similarly, kinetics of -catenin degradation were
addition of a recombinant purified SCF-Trcp1 complex identical in MEFs from the two genotypes after a release
to a prometaphase extract of -Trcp1/ cells strongly from a treatment with lithium chloride used to stabilize
rescues its ability to ubiquitinylate Emi1 (Figure 6C, lanes -catenin (not shown).
9–12), whereas recombinant purified SCFSkp2 complex The result that the bulk of IB and -catenin is de-
had no effect (not shown). Thus, the in vitro data are in graded independently of -Trcp1 prompted us to test
agreement with the in vivo results and indicate that the whether -Trcp2 was involved in regulating their stabil-
defect in Emi1 degradation observed in -Trcp1/ ity. To this end, we used the small interfering RNA
MEFs is due to its lack of -Trcp1-mediated ubiquitiny- (siRNA) technique to reduce the expression of -Trcp1
lation. and -Trcp2 in HeLa cells. When compared with HeLa
Because SCF substrates interact with the Fbps that cells transfected with a control double-stranded RNA
target them for ubiquitinylation, we asked whether (dsRNA) oligomer, cells transfected with two different
-Trcp1 and Emi1 physically interact in cultured cells. dsRNA oligomers corresponding to -Trcp1 showed no
Mammalian expression plasmids carrying either Flag- dramatic increase in the levels of -catenin and, when
tagged -Trcp1, Flag-tagged Fbw4, or Flag-tagged stimulated with TNF, they were still able to degrade
Fbw5 (two Fbps that, like -Trcp1, contain WD-40 do- IB (Figure 7G, lanes 4–6). This occurred despite the
mains) were transfected in HeLa cells. Endogenous fact that these oligomers almost completely downregu-
Emi1 was coimmunoprecipitated only with Flag-tagged lated -Trcp1 mRNA (Figure 7H, lane 2). Similar results
-Trcp1 (Figure 6D, lanes 1–4). To test whether this inter- were obtained when -Trcp2 was silenced with a spe-
action is mediated by the DSGxxS motif of Emi1, we cific oligomer (Figure 7G, lanes 13–15; Figure 7H, lane
expressed Flag-tagged -Trcp1 together with Myc- 5). In contrast, when we used an oligomer efficiently
tagged Emi1 (either wild-type or mutant). Emi1 but not targeting both -Trcp1 and -Trcp2 (Figure 7H, lane 3),
Emi1(S145A/149A) mutant was detected in anti-Flag im- we observed a dramatic accumulation of both -catenin
munoprecipitates (Figure 6D, lanes 5–7), confirming the and IB (Figure 7G, lanes 7–9 and 16–18). In agreement
importance of Ser145 and Ser149 in mediating the asso- with what was observed in -Trcp1/ MEFs, silencing
ciation between Emi1 and -Trcp1. of -Trcp1 alone induced Emi1 stabilization in prometa-
Taken together, these results demonstrate that Emi1
phase HeLa cells (Figure 7I, lanes 5–8 and 10–12) and
is a bona fide substrate of-Trcp1, which likely accounts
strongly delayed passage through mitosis (not shown).
for the stabilization of Emi1 observed in prometaphase
Interestingly, -Trcp2 silencing also induced accumula-
-Trcp1/ MEFs.
tion of Emi1 in prometaphase cells (Figure 7I, lanes 13–
15), which is in agreement with the ability of -Trcp2 toStabilization of IB and -Catenin Requires
physically interact with Emi1 (not shown) similarly tothe Silencing of Both -Trcp1 and -Trcp2
-Trcp1 (Figure 6D). Silencing of both -Trcp1 andA large body of literature reports that IB and -catenin
-Trcp2 has a more profound effect on Emi1 stabilizationare two major putative substrates of -Trcp1. We there-
as judged by measuring Emi1 half-life (Figure 7I, lanesfore examined whether the degradation of IB was
16–18).affected by the absence of -Trcp1. NFB activity was
Our data show that -Trcp1 and -Trcp2 are redun-stimulated in wild-type and -Trcp1-deficient MEFs with
dant in controlling the stability of -catenin and IB,tumor necrosis factor- (TNF; Figure 7A), IL-1 (Figure
whereas either-Trcp1 or-Trcp2 is required to regulate7B), lipopolysaccharide (LPS; Figure 7C), or a variety of
Emi1 stability.other stimuli or stresses (i.e., PMA, sorbitol, tuni-
camycin, H2O2, and UV; data not shown). We also stimu-
Discussionlated thymocytes with TNF (Figure 7D) and macro-
phages with LPS (Figure 7E). At different times after
A Role for -Trcp1 in Meiosis and Mitosisstimulation, cells were collected and lysed, and cell ex-
In this report, we show that -Trcp1 loss of function intracts were used for either immunoblotting or to mea-
mice does not affect viability but induces an impairmentsure NFB DNA binding activity by electrophoretic mo-
bility shift assay. We consistently observed normal of spermatogenesis and reduced fertility. This is likely
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Figure 5. Stabilization of Mitotic Regulatory Proteins in -Trcp1/ MEFs and Testes
(A) Expression of cell cycle regulatory proteins in cells reentering the cell cycle from quiescence. -Trcp1/ MEFs (lanes 1–6) and –Trcp1/
MEFs (lanes 7–12) were synchronized in G0/G1 by serum deprivation (lanes 1 and 7; indicated as time 0), trypsinized, replated, and then
reactivated with 20% serum. Cells were collected at the indicated times and protein extracts were analyzed by immunoblot with antibodies
to the indicated proteins.
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the result of the fact that a fraction of spermatocytes Several questions remain. Why is the most obvious
phenotype in -Trcp1-deficient mice reduced male fer-progresses slowly through meiosis (as shown by the
accumulating metaphase I spermatocytes), whereas a tility? Why is the penetrance of the phenotype found in
-Trcp1/ testes incomplete? If, in addition to a role indifferent fraction appears to divide abnormally and
eventually generate multinucleated spermatids. In turn, meiosis, -Trcp1 has a general role in somatic cells,
why is the in vivo phenotype not more dramatic? Onethese defects result in a greatly reduced number of sper-
matids and spermatozoa. possible general answer to these questions is provided
by the functional redundancy of the-Trcp1 and-Trcp2A hypomorphic mutation in the gene encoding Slimb,
the fly ortholog of -Trcp1, causes the appearance of gene products. Interestingly, although -Trcp1 and
-Trcp2 transcripts are expressed to approximately themetaphase figures, condensed chromosomes, and
polyploid figures in larval neuroblasts (Wojcik et al., same extent in most organs, testis is the organ in which
-Trcp1 (both human and mouse) is expressed at the2000). This mitotic phenotype is reminiscent of the mei-
otic phenotype observed in mouse germ cells lacking highest levels, whereas only low levels (as compared to
those in other organs) of -Trcp2 are expressed in this-Trcp1. To analyze mitotic progression in mouse so-
matic cells, we used MEFs and found that they have a organ (Cenciarelli et al., 1999; Koike et al., 2000; Maru-
yama et al., 2001). Accordingly, among many organslengthened mitosis. In addition, a fraction of -Trcp1/
MEFs displays centrosome overduplication associated examined, we observed an accumulation of Emi1 and
cyclin A only in testes. There could be a further reasonwith the presence of multipolar metaphase spindles and
misaligned chromosomes. These mitotic defects are for which spermatocytes are particularly sensitive to
-Trcp1 deficiency. Spermatocytes undergo two rapidlikely due to a stabilization of Emi1 specifically occurring
in M phase. Emi1 is a regulator of both mitosis and meiotic divisions without an intervening S phase to form
haploid spermatids. Our data show that despite the de-meiosis (Hsu et al., 2002; Reimann et al., 2001; Grosskor-
tenhaus and Sprenger, 2002; Reimann and Jackson, lay in degradation, Emi1 disappears from -Trcp1-defi-
cient MEFs reentering G1, like for the action of a different2002) by virtue of inhibiting the ubiquitin ligase complex
APC/C. This ubiquitin ligase controls the timely degrada- ubiquitin ligase. Thus, two subsequent meiotic divisions,
without the possibility to reset Emi1 levels as somatiction of a variety of important mitotic regulatory proteins,
a process that is necessary for the orderly progression cells do in G1, might translate into a more severe defect
in spermatocytes than in somatic cells. Yet, despitethrough the cell division cycle (reviewed by Peters,
2002). During the G1 phase of the cell cycle, APC/C Emi1 degradation being only decreased at M/G1 and
not totally inhibited, in cultured MEFs it is possible toneeds to be active to avoid any accumulation of mitotic
cyclins. During S and G2, Emi1 accumulates to cooper- uncover a lengthened progression through mitosis that
reveals an additional role for -Trcp1 in somatic cells.ate with cdks in inhibiting APC/C, thus allowing the ac-
cumulation of positive regulators of mitosis. Progression In conclusion, the -Trcp1 mouse knockout exposes an
unexpected critical role for this Fbp in regulating thethrough and exit from M phase require the reactivation
of APC/C. Our results strongly indicate that -Trcp1 progression through both meiosis and mitosis.
contributes to this reactivation by specifically mediating
the degradation of Emi1 in early mitosis. In fact, in the Centrosomal Overduplication in the Absence
of -Trcp1absence of -Trcp1, Emi1 is stabilized and mitotic
cyclins accumulate, likely as the result of an Emi1-medi- Cul1 and Skp1 play a key role in centriole splitting (re-
viewed by Hansen et al., 2002) as well as in later stepsated inhibition of APC/C. Accordingly, overexpression
of Emi1 in human cell lines (Hsu et al., 2002) and mouse of the centrosome cycle, as shown by the fact that en-
forced expression of a Cul1 dominant-negative mutantcells (not shown) induces their accumulation in prometa-
phase and metaphase. In conclusion, the stabilization induced multiple centrosome abnormalities, not only a
failure of the centrioles to separate (Piva et al., 2002).of Emi1 during M phase could explain why -Trcp1/
MEFs proceed more slowly through mitosis than wild- Interestingly, a fraction of -Trcp1/ MEFs displays
overduplication of centrosomes. Accordingly, a hypo-type cells. Similarly, the high levels of Emi1 found in
testes of -Trcp1-deficient mice are consistent with a morphic mutation in Slimb induces centrosome over-
duplication (Wojcik et al., 2000). The centrosome cyclestabilization of Emi1 in spermatocytes and could be the
reason for the meiotic defects. is uncoupled from the cell division cycle because
(B) Expression of cell cycle regulators in cells released from a block in prometaphase. -Trcp1/ MEFs (lanes 1–4) and -Trcp1–/– MEFs (lanes
5–10) were synchronized in prometaphase using nocodazole, and washed and replated in fresh medium. Cells were collected at the indicated
times after release and protein extracts were analyzed by immunoblot with antibodies to the indicated proteins.
(C) Expression of cell cycle regulators in cells released from a block in early S phase. -Trcp1/ MEFs (lanes 1–5) and -Trcp1–/– MEFs (lanes
6–10) were synchronized in early S phase using aphidicolin, washed, and then released from the block. Cells were collected at the indicated
times after release and protein extracts were analyzed by immunoblot with antibodies to the indicated proteins.
(D) Stabilization of Emi1 in prometaphase -Trcp1/ MEFs. Prometaphase MEFs were plated in the presence of cycloheximide. At the
indicated times, cells were collected and lysed, and extracts were subjected to immunoblotting with antibodies to Emi1 and Cul1 (top panels).
In the experiment shown in the bottom panel, MEFs were incubated with nocodazole for 12 hr, labeled with [35S]methionine and [35S]cysteine
for 45 min, and then chased with medium. At the indicated times, cells were collected and lysed, and extracts were subjected to immunoprecipi-
tation with an anti-Emi1 antibody under denaturing conditions followed by SDS-PAGE and autoradiography.
(E) Emi1 and cyclin A accumulate in testes of -trcp1/ mice. Different organs were collected from three sterile -Trcp1-deficient and three
littermate wild-type mice. Extracts from testis (lanes 1 and 2), spleen (lanes 3 and 4), pancreas (lanes 5 and 6), heart (lanes 7 and 8), lung
(lanes 9 and 10), kidney (lanes 11 and 12), and thymus (lanes 13 and 14) were immunoblotted with the antibodies to the indicated proteins.
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Figure 6. Emi1 Is a Bona Fide Substrate of -Trcp1 In Vivo and In Vitro
(A) Alignment of the amino acid regions corresponding to the putative -Trcp1 binding motif in Emi1 orthologs and in previously reported
-Trcp1 substrates.
(B) Wild-type Emi1 is only stable in -Trcp1–/– MEFs, whereas Emi1(S145A/S149A) mutant is stable both in -Trcp1–/– and -Trcp1/ MEFs.
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centrosomal duplication can occur in cells arrested ei- and -Trcp2 induces a dramatic accumulation of both
substrates. Thus, we can conclude that -Trcp1 andther at G1/S or in mitosis, hence generating multiple
centrosomes per cell. -Trcp1 deficiency might induce -Trcp2 are redundant in controlling the stability of IB
and -catenin, whereas both -Trcp1 and -Trcp2 regu-centrosomal overduplication by its ability to delay mito-
sis progression by increasing Emi1 levels and conse- late Emi1 stability. IB is targeted for degradation only
by homodimers of either -Trcp1 or -Trcp2 (Suzuki etquently inducing an inhibition of APC/C. In favor of this
hypothesis is the fact that overexpression of Emi1 al., 2000). The fact that silencing or inactivation of just
one of these two genes induces the accumulation ofcauses centrosomal overduplication and spindle abnor-
malities (our unpublished results) similar to what was Emi1 in prometaphase cells suggests that Emi1 is mostly
targeted by -Trcp1/-Trcp2 heterodimers.observed in -Trcp1-deficient MEFs. Furthermore,
cyclin A, an established substrate of APC/C, accumu- The results reported herein demonstrate a role for
-Trcp1 in the regulation of both meiosis and mitosis.lates in mitotic -Trcp1-deficient cells. Because cyclin
A is necessary for centrosomal division, we propose In addition, these findings indicate that the mitotic ubi-
quitin ligase APC/C is controlled by an SCF ubiquitinthat the stabilization of cyclin A, associated with a
lengthened mitosis, contributes to centrosomal over- ligase containing -Trcp1 as the substrate-targeting
subunit. Thus, SCF ligases act not only in interphase,duplication. Of course, additional APC/C substrates,
such as Aurora-A, Plk1, Cdc25a, and Nek2 might be as generally believed, but also regulate the timely pro-
gression through mitosis.stabilized as the result of APC/C inhibition by Emi1. In
turn, the accumulation of these proteins could contrib-
ute to the amplification and separation of centrosomes Experimental Procedures
in -Trcp1/ MEFs. In conclusion, -Trcp1 cooperates
Generation of -Trcp1/ Micewith Cul1 and Skp1 in regulating the centrosome cycle.
A full-length human -Trcp1 cDNA was used to screen a 
FIX II
mouse genomic library of 129SV/J strain (Stratagene). To confirm
-Trcp1 Substrates the identities of genomic clones, phage DNA was digested with XbaI
and the genomic fragments were subcloned into pBSK and analyzedHerein we report that Emi1 is a bona fide substrate of
by Southern blot and DNA sequencing. A 5.2 Kbp NotI-XhoI genomic-Trcp1 both in vivo and in vitro. Importantly, the in vitro
fragment containing two exons downstream of exon 5 (the F box-ubiquitinylation and the mitotic degradation of Emi1 are
encoding exon) was subcloned into the NotI-XhoI site of the pPNTdependent on the availability of Ser145 and Ser149,
targeting vector (Tybulewicz et al., 1991). A 3.8 Kbp intron fragment
which are present in a canonical -Trcp1 binding site extending from the XhoI site downstream of exon 4 to codon 153
conserved in Emi1 orthologs. Indeed, these two serine within exon 5 was modified with XbaI linkers and subcloned into
the XbaI site of pPNT between the neoR and thymidine kinase genes.residues are necessary for Emi1 to physically interact
The resultant targeting vector has a large portion of exon 5 thatwith-Trcp1. Although-Trcp1 is expressed throughout
encodes the almost complete F box of -Trcp1 plus an additionalthe cell cycle, its role in targeting Emi1 for degradation
22 amino acid region downstream of the F box (in total amino acidsappears to be specific for mitosis because no accumula-
154–212) deleted. This placed the neoR gene in an antisense orienta-
tion of Emi1 is observed in -Trcp1/ cells progressing tion and stop codons in all three reading frames within exon 5 at
through G1 and into S phase (Figure 5A). Thus, it is amino acid 153. In addition, the splicing acceptor site of exon 5 was
left intact. Finally, exons 6 and 7 are not in-frame with exon 4. Thispossible that Ser145 and Ser149 are specifically phos-
makes it unlikely to splice from exon 4 to exon 6 or 7, which wouldphorylated in mitosis, allowing the recognition of Emi1
generate a truncated form of -Trcp1 protein. The targeting vectorby -Trcp1.
was linearized and electroporated into D3 embryonic stem cells.As detailed in the Introduction, a large number of
Clones doubly resistant to G418 (300 g/ml) and gancyclovir (2 M)
studies has shown that -Trcp1 is necessary for tar- were tested for homologous recombination by Southern analysis.
geting IB and -catenin for degradation. Yet, MEFs Two genomic probes were used to confirm that homologous recom-
bination had occurred using HindIII or XbaI digests (in Figure 1A,from -Trcp1-deficient mice degrade both IB and
HindIII sites are indicated as H and XbaI sites as X). A neoR gene-catenin with kinetics similar to those observed in wild-
probe was used to insure that random integration of the targetingtype MEFs. Similarly, IB degradation is not inhibited
vector had not occurred elsewhere in the genome. Male chimerasin T cells or in macrophages. In addition, silencing of
produced F1 agouti animals, 50% of which were F1 heterozygotes.
either -Trcp1 or -Trcp2 alone does not dramatically Male and female F1 heterozygotes identified by Southern or geno-
affect the stability of IB and -catenin in HeLa cells, mic PCR analysis were interbred to produce F2 progeny. A genomic
PCR assay (Figure 1C) to detect the wild-type allele (372 bp) or thewhereas downregulation of the levels of both -Trcp1
MEFs were transfected with either Myc-tagged wild-type Emi1 (second panel from the top) or Myc-tagged Emi1(S145A/S149A) mutant (bottom
panel). Twenty-four hours later, prometaphase cells were plated in the presence of cycloheximide. At the indicated times, MEFs were collected
and lysed, and extracts were subjected to immunoblotting with antibodies to Myc (to detect exogenous Myc-tagged Emi1) and Cul1.
(C) Purified recombinant -Trcp1 rescues the ability of an extract from -Trcp1/ MEFs to ubiquitinylate Emi1 in vitro. In vitro ubiquitin ligation
of in vitro translated Emi1 was carried out with prometaphase extracts from wild-type MEFs (lanes 1–4) or -Trcp1-deficient MEFs in the
absence (lanes 5–8) or the presence (9–12) of purified recombinant SCF-Trcp1. The small bracket on the left side of the panels marks Emi1,
which progressively upshifted with time, likely because of phosphorylation events. The larger bracket marks a ladder of bands 50,000
corresponding to polyubiquitinylated Emi1.
(D) -Trcp1 binding to Emi1 depends on the DSGxxS motif present in Emi1. HeLa cells were transfected with an empty vector (lanes 1, 5,
and 8), Flag-tagged -Trcp1 (lanes 2, 6, 7, 9, and 10), Flag-tagged Fbw4 (lane 3), and Flag-tagged Fbw5 (lane 4) alone or in combination with
either Myc-tagged Emi1 (lanes 5, 6, 8, and 9) or Emi1(S145A/S149A) mutant (lanes 7 and 10). Cells were treated overnight with nocodazole
and with the proteasome inhibitor ZLLL for 3 hr prior to their harvesting and lysis. Extracts were either subjected to immunoprecipitation (IP)
with an anti-Flag antibody followed by immunoblotting (IB) as indicated (lanes 1–7), or directly to immunoblotting to check levels of expression
of wild-type and mutant Emi1 proteins (lanes 8–10).
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Figure 7. -Trcp1 and -Trcp2 Are Redundant in Controlling the Stability of IB and -Catenin
(A–E) IB degradation and NFB DNA binding activity are not affected by -Trcp1 deficiency. NFB activity was stimulated in MEFs (A–C),
thymocytes (D), and macrophages (E) with the indicated stimuli. Cells were then collected at the indicated times and lysed. Extracts were
subjected to electrophoretic mobility shift assay performed as described (Beg et al., 1993) using the palindromic B probe (Bours et al., 1992;
top panels) or to immunoblotting with antibodies to IB and Cul1.
(F) -catenin degradation is not affected by -Trcp1 deficiency. MEFs were treated with Wnt3a to induce -catenin. Two hours after treatment
(indicated as time 0), cells were washed and collected at the indicated times. Extracts were subjected to immunoblotting with antibodies to
-catenin and Cul1 (used as a loading control). Lanes 1 and 2 show basal levels of -catenin (prior to Wnt3a treatment).
(G and H) Silencing of both -Trcp1 and -Trcp2 stabilizes IB and -catenin.
(G) HeLa cells were transfected two times every 24 hr with siRNA molecules corresponding to a nonrelevant Fbp (lanes 1–3 and 10–12),
-Trcp1 (lanes 4–6), -Trcp2 (lanes 13–15), or to both -Trcp1 and -Trcp2 (-Trcp1/2; lanes 7–9 and 16–18). Forty-eight hours after the last
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mutant -Trcp1 allele (261 bp) was designed using a common D3 His-Skp1/Skp2 complexes were expressed in 5B insect cells and
purified by nickel-agarose chromatography as described (Carranoprimer (5-CTTCCTTATCTAACAGAAGATGGA-3) and either the
et al., 1999; Latres et al., 1999).-Trcp1 wild-type exon D1 primer (5-TCCTGACCATCCTCTCGATG
AGC-3) or the neoR gene L90 primer (5-TCTAATTCCATCAGAAGCTG
ImmunofluorescenceACT-3).
Cells were plated on glass coverslips coated (overnight at 4C) with
poly-L-lysine (100 g/ml in PBS), rinsed in PBS, and fixed for 10Autopsy and Histopathology
min in 4% paraformaldehyde/PBS at room temperature. ForApproximately 35 mice for each genotype at 1 and 1.5 year time
centrosomal staining only, cells were fixed for 10 min in cold metha-points and approximately 15 mice for each genotype between 6
nol (20C). Fixed cells were permeabilized with PBS/0.1% Tritonand 9 months were autopsied and all tissues were examined for
X-100 for 3 min, washed in PBS, and blocked with PTB buffer (PBS/gross abnormality. Tissues were formalin fixed, dehydrated, and
0.1% Triton X-100/0.3% BSA) for 30 min at room temperature. Incu-embedded in paraffin according to standard protocols. Sections (5
bation with primary antibodies was then carried out for 1–3 hr in am) were stained with hematoxylin and eosin (H&E) and examined
humidified chamber. After three washes in PBS, the coverslips weremicroscopically. Testes were isolated and punctured for effective
incubated for 30 min with Texas red-conjugated or FITC-conjugatedpenetration of the fixative. Testes and epididymes were fixed for 48
secondary antibody. All antibody reactions were carried out at roomhr in 10% PBS-buffered formalin at room temperature and embed-
temperature and dilutions were made in PTB buffer. Samples wereded in paraffin. Mounted sections were deparaffinized, rehydrated,
mounted in crystal/mount medium containing DAPI to identifyand stained with H&E or with periodic acid Schiff (PAS).
nuclei.
Cells, Cell Cycle Analyses, and Transient Transfections
Silencing by Small Interfering RNAPrimary MEFs were obtained from 12.5-day-old embryos as de-
Logarithmically growing HeLa cells were seeded at a density of 105scribed (Yamasaki et al., 1996). T cells and peritoneal macrophages
cells/6 cm dish and transfected with oligomers twice (at 24 andwere isolated according to published protocols (Latres et al., 2001;
48 hr after replating) using Oligofectamine (Invitrogen). Forty-eightJin and Conti, 2002). MEFs were synchronized in G0/G1 using low
hours after the last transfection, lysates were prepared and analyzedserum and in G1/S using aphidicolin as described (O’Connor and
by SDS-PAGE and immunoblotting. The siRNA oligomers used forJackman, 1995). MEFs and HeLa cells were synchronized in pro-
-Trcp1 silencing were 21 bp synthetic molecules correspondingmetaphase with 6–12 hr nocodazole treatment followed by mitotic
to nt 195–213 (oligo L, CCC AGG GAC UGG CGC ACU CdTdT) andshake-off as described (Carrano et al., 1999). Cell cycle synchrony
nt 1082–1100 (oligo H, UUC UCA CAG GCC AUA CAG GdTdT) ofwas monitored by flow cytometry and BrdU incorporation as de-
the human -Trcp1 coding region (NM_033637). For -Trcp2 silenc-scribed (Carrano and Pagano, 2001). Cells were transfected with
ing, we used an oligomer corresponding to nt 183–203 (oligo D,
FuGENE transfection reagent (Roche) according to the manufactur-
GAG GCC AUC AGA AGG AAA CdTdT) of the human -Trcp2 coding
er’s instructions.
region (AB033279). We also used an siRNA oligomer corresponding
to both nt 515–535 of human -Trcp1 and nt 262–282 of human
Immunological Procedures
-Trcp2 (oligo 1/2, GUG GAA UUU GUG GAA CAU CdTdT).
Rabbit polyclonal antibody (Pab) to -Trcp1 was generated using
the recombinant His--Trcp1 C-terminal fragment (residues 180– Acknowledgments
569), and Pab to Emi1 was against GST-Emi1. Rabbit Pabs to Cul1
(Latres et al., 1999), cyclin A (Carrano et al., 1999), cyclin B (Carrano We thank R. Bronson, T. Bashir, L. Di Marcotullio, V. Dorrello, G.
and Pagano, 2001), and Emi1 (Hsu et al., 2002) were previously Draetta, and A. Peschiaroli for their contribution to this work; K.
described. Mouse monoclonal antibodies to -tubulin, Flag, and Nakayama for communicating his results prior to publication; J.
Myc were from Sigma, to -catenin from BD-Transduction labs, Bloom, A. Hershko, K. Manova, and D. Wolgemuth for helpful discus-
to Skp1 from Zymed, and to BrdU from Roche. Rabbit Pabs to sions; A. Beg, Y. Ben-Neriah, A. Darwin, G. Franzoso, S. Fuchs, M.
phosphorylated Histone H3 was from Upstate, to IB from Santa Philips, D. Levy, A. Pellicer, V. Spiegelman, and Y. Weinrauch for
Cruz, and to 	-tubulin from Sigma. Unless specified, protein extrac- reagents and suggestions. M.P. is grateful to T.M. Thor for continu-
tion was performed as described (Carrano et al., 1999). Immunoblot ous support. This work was supported by an Italian American Cancer
analysis and immunoprecipitations were performed as described Foundation fellowship (1999-2000) and a Susan Komen Breast Can-
(Carrano et al., 1999). cer Foundation fellowship (2001 to present) to D.G., a fellowship
from the Japanese Ministry of Education, Culture, Sports, Science,
In Vivo Degradation Assays and In Vitro Ubiquitinylation Assay and Technology (2001) and the International Agency for Research
Wnt3a-transfected L cells (Shibamoto et al., 1998) were used as a on Cancer fellowship (2002) to Y.K., an Irma Hirschl Scholarship and
source of Wnt3a-conditioned medium. MEFs were Wnt3a stimulated grants from the NIH (R01-CA76584 and R01-GM57587) to M.P.; and
for 2 hr, then released in fresh medium, collected, and extracted as a Pew Scholarship and an NIH grant (R01-CA79646) to L.Y.
described (Liu et al., 2002). IB degradation experiments were
performed by incubating MEFs with TNF (10 ng/ml), IL-1 (10 ng/ml), Received: December 19, 2002
LPS (10 g/ml), PMA (100 ng/ml), sorbitol (0.6 M), tunicamycin (100 Revised: March 25, 2003
g/ml), and H2O2 (100 M). At the indicated times, MEFs were col- Accepted: April 3, 2003
lected and extracted according to Beg et al. (1993). Published: June 2, 2003
Two microliters of in vitro translated 35S-labeled Emi1 were incu-
bated at 30C in 10 l of ubiquitinylation mix (Montagnoli et al., References
1999) containing 20 g of cell extract obtained from prometaphase
MEFs as described (Montagnoli et al., 1999). Where indicated, ap- Bai, C., Sen, P., Hofman, K., Ma, L., Goebel, M., Harper, W., and
proximately 5 ng of purified recombinant SCF complexes were Elledge, S. (1996). Skp1 connects cell cycle regulators to the ubiqui-
added. Reaction products were run on SDS-PAGE followed by auto- tin proteolysis machinery through a novel motif, the F-box. Cell 86,
263–274.radiography. Roc1/Ha-Cul1/His-Skp1/-Trcp1 and Roc1/Ha-Cul1/
transfection, cells were treated with TNF to stimulate IB degradation. At the indicated times, cells were harvested and cell extracts were
analyzed by immunoblotting with antibodies to the indicated proteins.
(H) Aliquots at time 0 were used to analyze the expression of -Trcp1 (top panel), -Trcp2 (middle panel), and GAPDH (bottom panel) mRNAs.
(I) Silencing of either -Trcp1 or -Trcp2 induces stabilization of Emi1 in mitotic HeLa cells. Thirty-two hours after the last transfection with
the indicated oligomers, nocodazole was added for an additional 16 hr. Prometaphase cells were plated in the presence of cycloheximide
for the indicated times. Cells were then harvested and cell extracts were analyzed by immunoblotting with antibodies to the indicated proteins.
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